No black box warning on record for Aurlumyn

As of the latest FDA labeling reviewed, Aurlumyn (ILOPROST) does not carry a black box warning. Standard warnings and precautions still apply — see the full Aurlumyn medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS AURLUMYN may cause symptomatic hypotension. Monitor vital signs while initiating AURLUMYN. Correct hypotension prior to administration of AURLUMYN ( 5.1 ). 5.1 Hypotension AURLUMYN is a systemic vasodilator and may cause symptomatic hypotension. Correct hypotension prior to administration of AURLUMYN. Monitor vital signs while administering AURLUMYN. Consider temporary d

No black box warning on record for Aurlumyn

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS AURLUMYN may cause symptomatic hypotension. Monitor vital signs while initiating AURLUMYN. Correct hypotension prior to administration of AURLUMYN ( 5.1 ). 5.1 Hypotension AURLUMYN is a systemic vasodilator and may cause symptomatic hypotension. Correct hypotension prior to administration of AURLUMYN. Monitor vital signs while administering AURLUMYN. Consider temporary d

Aurlumyn Black Box Warning

No black box warning on record for Aurlumyn

Other warnings & precautions

Aurlumyn Black Box Warning

No black box warning on record for Aurlumyn

Other warnings & precautions